France General Surgical Devices Market - Growth, Trends, and Forecasts (2023 - 2028)

The French general surgical devices market is expected to register a CAGR of 4.5% during the forecast period.

A decline in patient admissions during the pandemic and the cancellation of non-emergency surgical procedures significantly impacted the French general surgical equipment business. According to a study published in British Medical Journal in November 2021, the weekly incidence of rhegmatogenous retinal detachment (RRD) surgical procedures decreased from 0.63/100,000 persons in 2019 to 0.36/100,000 inhabitants in 2020, representing a 41.6% decrease in the frequency of rhegmatogenous retinal detachment (RRD) surgical procedures. A decline in the surgical volume was observed in France during the pandemic period, severely impacting the market. However, the market has been recovering strongly since restrictions were eased. Over the projected period, an increase in surgical procedures, such as gynecological, neurological, and cardiological surgeries, will drive the recovery of the market.

The French market for general surgical devices is rapidly growing due to factors such as the rising demand for minimally invasive devices, increasing healthcare expenditures, and growing cases of injuries and accidents. According to the Institute for Health Metrics and Evaluation 2022, government health spending per person in France is expected to go up to USD 4,123 by 2050. With such high spending on healthcare, the government of France is expected to increase the adoption of standard healthcare and advanced surgical devices, thus propelling market growth.

Moreover, a growing geriatric population that is more prone to chronic diseases and requires surgical treatment is likely to support the growth of the market. For instance, according to the United Nations Population Fund's, World Population Dashboard's Statistics 2021, about 21.1% of individuals in France are 65 or older. Since chronic diseases are more common among the elderly, the need for surgeries and treatment devices is predicted to rise over the forecast period.

Thus, all aforementioned factors are expected to boost market growth over the forecast period. However, stringent government regulations and improper reimbursement for surgical devices may restrain the market growth.

France General Surgical Devices Market Trends

Handheld Devices is Expected to Hold a Significant Share of the Market

The development of advanced devices, like robotic handheld surgical devices for laparoscopic interventions, enhances a surgeon's dexterity. Needle holders are very similar to hemostats in shape, featuring jaws and handles. Needle holders allow the needle to be locked into place for suturing in various tissue types. The market is growing due to the rise in minimally invasive surgical procedures and an increase in outpatient surgeries.

In France, the rising number of surgeries led to the increasing use of handheld surgical devices. For instance, as per the Organization for Economic Co-operation and Development (OECD) data in 2022, in France, around 62,206 laparoscopic appendectomy procedures, 110,848 laparoscopic cholecystectomy procedures, and 147,553 cesarean section procedures were performed in 2020. Thus, a growing number of surgical procedures is likely to increase the demand for handheld devices in the future.

Additionally, product launches by key market players are expected to boost the market in the country. For instance, in March 2022, Saintonge Hospital in France purchased and installed cutting-edge Dexter surgical equipment. Dexter's clinical adaptability will help enhance patient outcomes in general surgery, gynecology, and urology by providing on-demand robotic assistance. This novel idea enables laparoscopic surgeons to select their favorite equipment for each step of a surgical operation.

Thus, the aforementioned factors are expected to boost the growth of the segment over the forecast period.

Neurology is Expected to Hold Significant Share the France General Surgical Devices Market

Neurological surgical devices are medical devices that help treat various neurological disorders and conditions, such as Alzheimer's disease, Parkinson's disease, major depression, and traumatic brain injury. The increasing burden of neurological disorders among the population is the key factor driving the demand for neurology Surgery and thus for surgical devices. According to the Alzheimer's Association 2022, in France, more than 1,175,000 people are living with Alzheimer's disease, and more than 200,000 people have diagnosed with Alzheimer's or another dementia each year. Such a huge number of Alzheimer's patients in France will lead to demand for neurological surgeries, ultimately increasing demand for surgical devices in the country.

Furthermore, rising initiatives from the key market players in France to bring technologically advanced surgical devices into the market. For instance, in December 2021, eCential Robots, a Grenoble-based Medtech specializing in surgical robotics, and the European Investment Bank (EIB) signed a EUR 15 million funding agreement. The operation intends to fund research and innovation to enable the company to reach its goal of becoming the operating room's digital surgery and robotics standard for neuro-musculoskeletal surgery.

Thus, all aforementioned factors such as the growing burden of neurological diseases and strategic initiatives by market players are expected to boost the segment growth over the forecast period.

France General Surgical Devices Market Competitor Analysis

The French general surgical devices market is moderately competitive due to the presence of many large, medium, and small players. Some major players in the market are B. Braun Melsungen AG, Boston Scientific Corporation, Cadence Inc., Conmed Corporation, and Johnson & Johnson, among others. Most companies undertake strategic initiatives, such as product development, geographical expansion, and M&A, to increase their market share.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support